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I. Introduction 
This report summarizes information regarding morbidity 
and mortality in ischemic heart disease as it relates to 
insurability and employability. Insurability requires the as- 
sessment and evaluation of risks that may relate to life, 
disability and health. Employability should consider three 
aspects: 1) the capability of the individual to perform the job, 
2) the risk to the individual of performing the job, and 3) the 
risk to society if the individual is performing the job. 
This report focuses primarily on the assessment of risk of 
patients with chronic ischemic heart disease, including def- 
inite or probable angina pectoris, previous myocardial in- 
farction, cardiac arrest or documented significant coronary 
artery obstruction. It focuses primarily on chronic disease 
outcomes and does not address the early prognosis of 
patients presenting with acute myocardial infarction. In 
addition, the risk to society posed by ischemic heart disease 
events occurring on the job is considered for individuals 
without manifestations of coronary artery disease. Prognos- 
tic risk focuses primarily on survival, but also encompasses 
subsequent myocardial infarction. The effects of specific 
therapies on prognosis and changes in the natural history of 
the disease are also considered. 
II. Sources of Information 
Three types of studies that have recently been exten- 
sively reviewed (1) concern prognosis in patients with isch- 
emit heart disease: 1) U.S. population statistics, 2) cohort or 
observational studies, and 3) randomized clinical trials. 
U.S. population statistics. These data, obtained from na- 
tional surveys, census figures and publications from the 
American Heart Association (2-5), provide limited informa- 
tion for the evaluation of specific individuals, and there are 
hazards in extrapolating results from specific studies to 
national statistics (6-8). 
Cohort or observation studies. These studies define the 
population through community or regional surveillance. 
Findings from these studies can be extrapolated to the U.S. 
population because the study population is generally repre- 
01989 by the American College of Cardiology 
sentative of the U.S. population as a whole. The findings 
from several large studies (the Framingham Study, Tecum- 
seh Study, Chicago Peoples Gas Company Study, Minneap- 
olis Professional and Business Men, U.S. Railroad Workers 
studies and the Chicago Western Electric Company study) 
largely agree with each other. The risk of developing coro- 
nary heart disease among asymptomatic individuals as it 
relates to the initial assessment has been defined by these 
studies. Estimates from the Framingham Study form the 
basis of the Coronary Risk Handbook (9). 
Most of the detailed information regarding the assessment 
of risk of individual patients with manifest ischemic heart 
disease is derived from specific cohort studies of individuals 
with the disease. In general, these studies provide the most 
detailed assessment of the importance of characteristics 
influencing prognosis but suffer from the selection bias 
introduced from the enrollment process and criterion selec- 
tion. The Coronary Artery Surgery Study (CASS) trial 
included a large collaborative patient registry of all individ- 
uals catheterized at participating centers (10). Collaborative 
registries of patients with acute myocardial infarction in- 
clude the Myocardial Infarction Limitation of Size (MILIS) 
Study (1 I), the Multicenter Postinfarction Trial (MPIT) (12) 
and those coordinated at San Diego (13) and Stanford (14); 
however, this report focuses primarily on nonacute disease. 
Voluntary collaborative registries include the National 
Heart, Lung, and Blood Institute-Percutaneous Transluminal 
Coronary Angioplasty (PTCA) registry of patients undergoing 
percutaneous transluminal coronary angioplasty (15). There 
are large regionally-based databases describing complete as- 
sessment and outcome of patients undergoing cardiac cathe- 
terization or other specific procedures at one or more institu- 
tions. These include the Duke Database for Cardiovascular 
Disease (16), the Seattle Heart Watch Study (17), the Cleve- 
land Clinic Registry (18), the University of Alabama Registry 
(19) and the Emory University Registry (20). Prognostic 
studies of specific groups of patients undergoing tests or 
procedures include those from Cedars-Sinai Hospital (21). 
Randomized controlled trials. These trials have evaluated 
not only the outcome of coronary bypass surgery and medical 
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Table 1. Prognostic Characteristics From the Initial Assessment 
Analysis 
Characteristics Univariate Multivariate 
Age 
Gender 
Risk factors 
Smoking 
Hypercholesterolemia 
Hypertension 
Diabetes 
Symptoms 
Pain type 
Duration 
Course 
Nocturnal 
Frequency 
Myocardial damage 
Congestive heart failure or class 
ST-T wave changes 
Ventricular gallop 
Cardiomegaly 
Premature ventricular 
complexes 
History of myocardial infarction 
Q waves on electrocardiogram 
Digitalis use 
Diuretic use 
Rales 
Heart murmur 
Left ventricular hypertrophy 
Conduction abnormalities 
Peripheral vascular disease 
CA, CL, D. I. S 
CA. D. 1 
CA, CL. D. I 
D. 1 
CA, CL. D. 1. S. V 
CL. D. S 
D. S 
CL. D. S 
CA, CL, D. V 
D 
D. S 
CA, CL. D. S 
CL, D. S. V 
D. S 
CA. CL. D. S 
D. S 
CA, D. V 
CL, D. S 
CA, S 
CA, S 
D. S 
D. S 
CL. D. S 
CL. D. S 
CL. D. E, S 
CA, D, S 
CA. D 
CA 
CA. CL. V 
CL 
D 
CL 
CA. D. V 
CL, D, S 
CL, D. S, V 
D 
CA. D. S 
D 
0. V 
CL, D 
CL. s 
CL. D 
CL. D 
CA = Coronary Artery Surgery Study Trial and Registry (10.94983: CL 
= Cleveland Clinic Registry (18.103): D = Duke University Database (l&99- 
101): E = European Coronary Surgery Study (90-93): 1 = Life Insurance 
Studies (1,104): S = Seattle Heart Center Watch Registry (17.??.101): V = 
Veterans Administration Cooperative Trial (87-89). 
therapy but also changes in the natural history of ischemic 
heart disease. Assessments of prognosis provided by these 
studies are limited by selection bias introduced by who is 
enrolled in the trial and difficulties in generalizing beyond 
these subjects of patients. This report summarizes the three 
largest trials in patients with stable angina: the Veterans 
Administration Cooperative Trial, the European Coronary 
Surgery Study and the Coronary Artery Surgery Study. 
III. Characterization of Prognosis 
A. Prognostic Characteristics From the 
Initial Assessment 
Table 1 shows significant prognostic variables from the 
initial assessment that have been found to be important in at 
least two of the seven major studies. Where the relation has 
been examined for the characteristic alone and found to be 
significant, an appropriate notation has been made in the 
univariate column. Where multivariate analyses have been 
performed including at least several of the characteristics 
(uncommon for the randomized clinical trials) and the char- 
acteristics have remained important, an appropriate notation 
has been made in the multivariate column. The prognostic 
evaluation of a patient with coronary artery disease begins 
with the physician’s initial assessment. Decisions to perform 
noninvasive testing or cardiac catheterization should be 
considered in light of what these tests add to the physician’s 
initial assessment. 
Clinical perspective versus life insurance perspective on 
prognosis. Many different characteristics from the physi- 
cian’s initial assessment can be used to predict survival. 
Their importance as they relate to prognosis depends in part 
on how an individual’s prognosis is considered. The prog- 
nostic risk from a life insurance perspective compares the 
risk of an individual with coronary artery disease with that 
which would be expected for an individual of similar age and 
gender. Clinicians generally consider the prognosis from the 
perspective of the importance of individual characteristics 
among patients with established disease. This difference in 
perspective regarding prognosis influences the importance 
assigned to characteristics from the initial assessment. 
Factors affecting prognosis. Among patients with estab- 
lished coronary artery disease, clinical prognosis worsens 
with age. However, when considered from a life insurance 
perspective. the relation reverses (relative mortality in isch- 
emit heart disease patients is considerably higher in younger 
than in older age groups) because the assigned risk of the 
individual with coronary artery disease is related to the 
expected risk in a comparable healthy population. Conse- 
quently. age is an important prognostic characteristic and of 
fundamental importance when considered from the life in- 
surance perspective. 
Other important prognostic characteristics from the initial 
assessment include the patient’s gender. risk factors, symp- 
toms, evidence of myocardial damage and evidence of 
associated vascular disease. The importance of gender is 
marginal in patients with established disease. although this 
characteristic is very important in operative mortality with 
coronary artery bypass grafting, most likely related to the 
smaller size of coronary vessels in women. Risk factors are 
particularly important in relation to the risk of development 
of coronary artery disease. but their contribution to progno- 
sis is less important among patients with established disease 
(16.22). When examined by themselves, they clearly identify 
subgroups at higher risk, but when considered in conjunction 
with other characteristics, their contribution is less impor- 
tant. Similarly, psychological constructs such as the type A 
personality appear to be important in the development of the 
disease. but evidence of their importance as independent 
prognostic variables is not convincing. 
Tlw prcsencc c?f’signijicxnr myxurdial drtmugr has been 
found in all studies to be an important predictor of outcome. 
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Table 2. Prognostic Characteristics: Treadmill Exercise Testing 
Studies (reference no.) 
Univariate Analysis 
23, 24, 27, 105-t 11 
23, 24, 105-107 
23, 94, 105, 107, 109-112 
23. 94, 105, 111, 114 
23, 105, 115, 116 
117 
24. 118 
Multivariate Add to Cardiac 
Analysis Catheterization 
23, 94, 105 105 
105 105 
94, 105, 107, 113 94, 105, 113 
23, 94 94 
23 - 
- - 
- - 
Characteristic 
ST segment change 
Treadmill angina 
Treadmill time or stage 
Maximal heart rate 
Ventricular arrhythmias 
Angina1 heart rate 
Exertional hypotension 
In essence, this characteristic reflects the presence and 
extent of previous myocardial infarction and is often asso- 
ciated with symptoms of congestive heart failure. 
Anginal symptoms identify individuals with myocardium 
at risk, and their tempo reflects the severity of the risk. 
Longstanding angina reflects longstanding coronary artery 
disease and, because the disease is progressive in nature, 
suggests a worsening anatomic severity. 
B. Prognostic Characteristics Elicited by 
Noninvasive Testing 
Noninvasive testing has been able to identify high and 
low risk subgroups of patients with chronic coronary artery 
disease. In general, studies are relatively small in size and, to 
provide sufficient events, have often combined end points to 
include not only death but also myocardial infarction and 
coronary artery bypass grafting. 
The treadmill exercise test. This test has been the most 
carefully studied and excellent reviews are available (23-26). 
The studies cited in Table 2 indicate that among the many 
exercise variables evaluated, the most important prognostic 
indicators are maximal exercise capacity, increases in sys- 
tolic blood pressure, and ST segment displacement (depres- 
sion and elevation) (27). Although uncommon, exertional 
hypotension and ventricular tachycardia also identify a high 
risk subgroup of patients. The magnitude of the additional 
Table 3. Prognostic Characteristics: Radionuclide Angiography 
Studies (reference no.) 
Characteristic 
Exercise ejection fraction 
Change in ejection fraction 
Rest ejection fraction 
Angina 
ECG changes 
Wall motion abnormalities 
Exercise time 
Rest end-diastolic volume 
Univariate 
Analysis 
119, 120 
121 
119-121 
120 
120 
119 
Multivariate 
Analysis 
120 
119 
prognostic information provided by exercise testing is con- 
siderable in relation to the initial assessment and compara- 
tively modest where catheterization has been performed 
(28,29). 
Nuclear studies. Important prognostic characteristics ob- 
tained with radionuclide angiography and with thallium 
scintigraphy are shown in Tables 3 and 4, respectively. The 
radionuclide exercise ejection fraction appears to be the 
most important prognostic variable. In patients with a nor- 
mal rest ejection fraction, the change in ejection fraction 
with exercise and the peak exercise ejection fraction provide 
virtually identical prognostic information. Perfusion defects 
in the distribution of two or more coronary arteries, and 
perhaps the quantitative estimate of the magnitude of hypo- 
perfusion or the uptake of thallium in the lung appear to be 
the most important thallium prognostic variables. The con- 
tributions of radionuclide angiography and thallium scintig- 
raphy to prognostic assessment are similar. 
Ambulatory electrocardiography. This has also been per- 
formed in large series of patients with acute myocardial 
infarction and chronic angina. In patients with acute myo- 
cardial infarction, two large observational studies (11,12) 
have shown that frequent premature ventricular complexes 
on a predischarge 24 h ambulatory ECG are predictive of 
impaired prognosis independently of left ventricular func- 
tion. Similar observations have been made in patients with 
Table 4. Prognostic Characteristics: Thallium Scintigraphy 
Characteristic 
Transient defects 
Total or fixed defects 
Degree of hypoperfusion 
Lung thallium uptake 
Exercise ST changes 
Heart rate changes 
Exercise ventricular arrhythmia 
Studies (reference no.) 
Univariate 
Analysis 
21, 122-124 
21, 122, 125 
21 
126 
124. 126 
124 
124 
Multivariate 
Analysis 
21, 122, 124 
123 
21 
126 
124, 126 
124 
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Table 5. Prognostic Characteristics: Cardiac Catheterization 
Studies 
Univariate Multivariate 
Analysis Analysis 
Ventricular function 
Ejection fraction CA. D. I. S CA. D. S 
LV score or wall motion abnormalities CA. CL. D. S CA. CL. D 
Anatomy 
Left main disease CA. D. 1. V CA. D. V 
Number of diseased vessels CA. CL. D. E. 1. S. V CA. CL, D. S 
Proximal LAD CA. D. S CA. D 
Other proximal disease or jeopardy score CA. D CA, D 
Mitral regurgitation CA, 0. S CA. D. S 
LVEDP CL. D, S CL, D. S 
CA = CASS Trial and Registry (10.94-98): CL = Cleveland Clinic Registry (18,103); D = Duke University 
Database (16.99-101): E = European Coronary Surgery Study (90-931: I = Life Insurance studies (I, 104): LAD = 
Left anterior descending coronary artery; LV = Left ventricular coronary artery: LVEDP = Left ventricular 
end-diastolic pressure: S = Seattle Heart Center Watch Registry (17. 22. IO?): V = VA Trial (X7-89). 
congestive heart failure (30). but this relation has not been 
found in patients with angina requiring cardiac catheteriza- 
tion (31). Premature ventricular complexes occur more fre- 
quently in patients with reduced left ventricular function, 
and their prognostic information overlaps with measure- 
ments of left ventricular function (31). Evidence of silent 
ischemia has also been shown to be related to prognosis. 
although the data are not fully developed. 
Exercise echocardiography. This study may also identify 
patients with a poor prognosis through assessment of wall 
motion changes. however, the data are not fully developed. 
C. Prognostic Characteristics From the 
Cardiac Catheterization 
Prognostically important characteristics from cardiac 
catheterization are shown in Table 5. Information from the 
physician’s initial assessment and cardiac catheterization is 
shown in Table 6. 
The prognostically most important characteristics from 
the catheterization reflect left ventricular function and cor- 
onary anatomy. Left ventricular function is usually ex- 
pressed as the ejection fraction. Anatomic characteristics 
reflecting myocardial jeopardy include the degree of left 
main stenosis, the number of significantly diseased major 
coronary vessels and the presence of proximal disease in the 
major coronary arteries, particularly of the left anterior 
descending coronary artery. The severity of mitral regurgi- 
tation and elevated left ventricular end-diastolic pressure are 
also prognostically important. 
Important characteristics from the initial assessment com- 
bined with the cardiac catheterization are shown in Table 6. 
The most important predictors of survival are left ventricular 
function and coronary anatomy. Patients with unstable angina 
or poor left ventricular function and severe congestive heart 
failure have an especially unfavorable prognosis. The pres- 
ence of other vascular disease, mitral regurgitation and age 
have also been found to be significant predictors of outcome 
when considered with information from cardiac catheteriza- 
tion. When examined by themselves, risk factors clearly 
identify subgroups at higher risk but when considered in 
conjunction with the characteristics shown in Table 6, their 
contribution is less important. The importance of gender is 
marginal in patients with established disease. 
Prognostic estimates are most discriminating when all 
characteristics are considered. For example, consider the 
prognosis of two patients with three vessel disease and a 
normal ejection fraction. One is 64. has frequent angina, 
resting ST depression, peripheral vascular disease, previous 
myocardial infarction, an ejection fraction of 5 1% and a 95% 
Table 6. Summary of Important Prognostic Characteristics: Initial 
Assessment and Catheterization 
Studies 
Univariate Multivariate 
Analysis Analysis 
Age CA. CL. D. 1. S CA. CL, D, S 
Gender CA. D. I CA. D 
Risk factors CA. CL. D. I. S. V CA, CL, V 
Symptoms CA. CL. D. S. V CA. CL, D. S. V 
Myocardial damage All All 
Vascular disease CA, CL. D. E, S CA. CL, D. E 
Conduction abnormalities CL. D, S CL, D. S 
Anatomy All All 
LV function CA. CL. D. I. S. V CA4. CL. D. S. V 
Mitral regurgitation CA, D. S D. S 
CA = Coronary Artery Surgery Study Trial and Registry (lO,Y4-98); CL 
= Cleveland Clinic Registry (18,103); D = Duke University Database (16, 
99-101): E = European Coronary Surgery Study (9&93); I = Life Insurance 
studies (1.104): LV = left ventricular: S = Seattle Heart Center Watch 
Registry (17.22.102): V = Veterans Administration Trial (87-89). 
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proximal left anterior descending coronary artery lesion. The 
other is 51, has infrequent angina, no peripheral vascular 
disease or previous myocardial infarction, an ejection fraction 
of 64% and a distal 75% left anterior descending coronary 
artery lesion. Expected survival on medical therapy is quite 
different. Five year estimates from the Duke Database (32) 
are 42% for the first patient and 92% for the second. 
IV. Effects of Therapy on Prognosis 
nosis is unknown at present. The improved patency of 
internal mammary artery grafting compared with saphenous 
vein bypass procedures may improve or extend survival 
benefits with surgery (5859). 
Primary characteristics influencing operative mortality 
include age, body size (identified by gender in many studies), 
hypertension, prior coronary artery bypass grafting, history 
of smoking, left ventricular function, extent of anatomical 
disease, the presence of unstable angina or recent myocar- 
dial infarction, cerebral or peripheral vascular disease, and 
renal or pulmonary dysfunction (60-62) (Hammermeister 
KE. Seattle Heart Watch 1988 [personal communication]. 
Pryor DB. Duke Database 1988 [personal communication]). 
Long-term outcome after coronary artery bypass grafting is 
influenced by the same characteristics that define the risk in 
medically-treated patients except that coronary anatomy is 
Studies of prognosis in ischemic heart disease must con- 
sider the ameliorating effects of therapy, including medical 
therapy, coronary artery bypass grafting, coronary angio- 
plasty and changes over time in the natural history of the 
disease. 
A. Medical Therapy 
much less important. 
The influence of risk factor modification and drug therapy 
on the prognosis of patients with established disease has 
been reviewed (1,33). In general, serum cholesterol, hyper- 
tension and particularly smoking behavior worsen the prog- 
nosis of patients with manifest ischemic heart disease. 
However, the influence of these characteristics on recurrent 
cardiac events is modest compared with their influence on 
the incidence of initial coronary events (34-41). Although 
therapy directed at modifying these risk factors remains a 
prudent recommendation, definitive demonstration of sub- 
stantially improved survival with risk factor modification in 
patients with chronic stable angina is limited (40). 
C. Coronary Angioplasty 
The value of angioplasty in modifying prognosis in pa- 
tients with coronary artery disease is unknown (63,64). The 
major limitation with respect to long-term prognosis appears 
to be restenosis occurring within 6 months in approximately 
one-third of treated patients (65,66). 
D. Changes in the Natural History of Zschemic 
Heart Disease 
There is overwhelming evidence that the natural history 
of coronary artery disease in the United States is improving 
over time. A recent comprehensive review describes a 42% 
decline in the age-adjusted mortality rates in the U.S. 
population between 1963 and 1985 (67). Outcomes have 
improved for patients with acute myocardial infarction 
(34,68) and those undergoing coronary artery bypass surgery 
(69). Improvements for patients with chronic stable angina 
treated medically are more modest (34,69,70). 
Trials of drug therapy in modifying medical prognosis have 
been largely limited to patients with acute myocardial infarc- 
tion or unstable angina. Evidence for an improved outcome, 
due to beta-blocker therapy, is more convincing after acute 
myocardial infarction (42-44) than in chronic angina 
(26,45,46). Two studies (47,48) have shown dramatic benefit 
of aspirin therapy in patients hospitalized with unstable an- 
gina. Some benefit for calcium channel blocker therapy may 
also be present (49). Vasodilator therapy may also improve 
survival in patients with congestive heart failure including 
some patients with coronary artery disease (50,51). The 
evidence for the use of antiarrhythmic therapy is controver- 
V. Consideration of Occupations Posing a 
Risk to Society 
B. Coronary Artery Bypass Graft Surgery 
The value of surgery in modifying prognosis has been 
excellently reviewed (1,52-54). In general, the magnitude of 
the improvement in prognosis is greatest in patients with 
anatomically extensive disease (left main disease and three 
vessel disease) or high risk based on clinical evaluation. 
Improvement is sustained in the first 7 to 8 years after 
surgery, diminishing thereafter as grafts become occluded 
(55,56,57). The influence of repeat bypass grafting on prog- 
Clinicians are frequently asked to “certify” that it is 
appropriate for an individual with ischemic heart disease to 
return to work. Such decisions are especially important in 
public safety officers, firefighters, pilots, critical process 
operators (e.g., nuclear power plant operators) and profes- 
sional drivers. A significant cardiac event such as cardiac 
arrest or myocardial infarction occurring at a “critical” time 
in such occupations may adversely affect not only the 
individual but also the public or coworkers. In “certifying” 
whether it is appropriate for such individuals to work, the 
physician should consider not only the risk to the individual, 
but also the risk to society. 
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Prognostic concerns about coronary heart disease have led 
to the mandatory retirement of individuals with demonstrated 
disease, as well as individuals without manifest disease. 
These two groups will be considered separately with respect 
to both the risk to the individual and the risk to society. 
A. Asymptomatic Individuals Without Manifest 
Coronary Disease 
In general, there is no convincing evidence that employ- 
ment in a specific occupation worsens an individual’s risk for 
the occurrence of a cardiac event. A possible exception is 
firefighting, which entails bursts of heavy physical activity 
and exposure to heat and psychological stress. The risk of 
cardiac events in individuals without manifest coronary 
disease can be estimated with use of standard risk factor 
equations such as the Coronary Risk Handbook (9) based on 
the Framingham Study. 
Epidemiologic studies suggest that habitual physical ex- 
ercise may offer some protection against primary or second- 
ary events of coronary heart disease and associated mortal- 
ity but “falls short of proving” (71) this. The evidence also 
suggests that the effect of exercise training is outweighed by 
the other risk factors. There has also been some demonstra- 
tion that emotional stress and sudden bursts of activity may 
increase the risk of sudden death, particularly in sedentary 
individuals (72.73). 
Risk factor profiling using techniques such as the Coro- 
nary Risk Handbook are accurate and well substantiated. 
Screening programs to detect individuals without manifest 
coronary disease should consider such strategies rather than 
relying solely on individual characteristics such as age. 
gender, smoking, and others. Exercise testing can further 
improve the identification of individuals with one or more 
risk factors (74-77) and can be applied economically to 
specific occupations (78). In some cases, such as for airline 
pilots. it may be appropriate to consider further evaluation 
with radionuclide procedures or coronary angiography, or 
both, for individuals at increased risk (7%84). 
B. Symptomatic. Individuals 
Whether it is appropriate for symptomatic individuals to 
return to occupations posing a risk to the public is often 
difficult to determine. From a prognostic standpoint, the goal 
is to determine whether the job is likely to place the 
individual under a stress that would otherwise be unlikely to 
occur. However, it is difficult to duplicate or simulate 
on-the-job conditions. such as those encountered in fire- 
fighting (85,86), in a standard ECG stress laboratory. 
The decision should also consider the status of the 
patient’s disease. The risk of death or infarction is substan- 
tially higher in individuals with manifest or symptomatic 
coronary disease than in those without manifest disease. The 
Table 7. Prognostic Characteristics Classified by Pathophysiologic 
Construct and Weighted According to Power in Predicting 
Prognosis for Patients With Manifest Coronary Artery Disease 
Pathophysiologic Construct Weight 
Myocardial function 
Congestive heart failure 
Functional class 
Diuretic use 
Digitalis use 
Cardiomegaly 
S, gallop 
Prior myocardial infarction 
Exercise systolic pressure 
Exercise capacity 
Ventricular arrhythmias 
Qection fraction 
Wall motion score or assessment 
Left ventricular end-diastolic pressure 
Myocardial jeopardy 
Angina frequency 
Duration of angina 
Level of exercise inducing ischemia 
Degree of exercise induced ST segment depression 
Exerctse systolic pressure 
Presence and extent of reversible thallium uptake 
Number and distribution of coronary vessels with obstruction 
Myocardial ischemia 
Rest or nocturnal angina 
Progressive angina 
Unstable angma 
Failure of angina to respond to nitroglycerin 
ST segment depression on rest ECG 
tttt 
ttt 
tt 
tt 
ttt 
ttt 
tt 
ttt 
tttt 
t+ 
tttt 
tttt 
tt 
t 
ttt 
ttt 
ttt 
ttt 
ttt 
ttt 
tt 
ttt 
tt 
ttt 
prognostic value of silent ischemia, defined as ST segment 
depression without chest pain, in patients without manifest 
coronary artery disease is unknown. For certain groups of 
patients, such as those with unstable angina, return to work 
is clearly inappropriate in a setting where the occurrence of 
a significant cardiac event would place the public at risk. In 
contrast, individuals without clinical or angiographic evi- 
dence of myocardial ischemia after coronary artery bypass 
grafting have an excellent prognosis (82). 
VI. Conclusions 
I. Variables from the clinical assessment, noninvasive 
tests and cardiac catheterization that are important for esti- 
mating prognosis include descriptors of myocardial function, 
myocardial jeopardy and myocardial ischemia (Table 7). 
2. Prognosis can be estimated from the clinical examina- 
tion (history, physical examination, ECG, chest roentgeno- 
gram) combined when indicated with one or more noninva- 
sive studies (e.g., exercise test, radionuclide angiography, 
myocardial imaging or echocardiography) and does not 
usually require cardiac catheterization except when dictated 
by regulations or recommendations. 
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3. Most occupations do not increase the risk of coronary 
events. In patients with manifest coronary disease, contin- 
ued employment should be permitted when patients are 
functionally able to perform the job. 
4. Prognosis should be estimated for occupations in which 
sudden disability might endanger others. For patients with 
manifest disease, this evaluation should occur at yearly 
intervals, or more frequently if required by regulation or 
recommendation. The cost effectiveness of these approaches 
needs to be evaluated. 
5. Prognosis should also be estimated for patients in 
occupations requiring sudden or sustained high level physi- 
cal effort or exposure to extremes of hot or cold or to 
hypoxia, hypercarbia, carbon monoxide or stimuli producing 
sudden bursts of autonomic activity. 
6. Prognosis need not be estimated for individuals without 
manifest coronary disease, except perhaps for those with 
occupations in which sudden disability might endanger oth- 
ers. In the latter group, noninvasive assessment may be of 
value. In some instances, cardiac catheterization may be 
required to satisfy regulations or recommendations. 
7. Although the advisability of return to full-time work of 
individuals with manifest coronary disease can usually be 
established a priori, a trial work period may sometimes be 
necessary. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
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Task Force II: Determination of Occupational Working Capacity in 
Patients With Ischemic Heart Disease 
WILLIAM L. HASKELL, PHD, FACC, CHAIRMAN, NORMAN BRACHFELD, MD, FACC, 
ROBERT A. BRUCE, MD, FACC, PAUL 0. DAVIS, PHD, CHARLES A. DENNIS, MD, FACC, 
SAMUEL M. FOX III, MD, FACC, PETER HANSON, MD, ARTHUR S. LEON, MD, FACC 
Introduction 
The physical, metabolic and cardiovascular demands of 
occupations in industrialized countries have substantially 
declined during the past century. Many jobs that once 
required substantial physical effort are now performed by 
machines, robots or computers. This decrease in job-related 
energy demand is especially apparent in occupations per- 
formed by people over age 40, who, given some seniority, 
rarely perform physical tasks exceeding a peak energy 
expenditure of 5 kcaVmin or 3.5 METS, where 1 MET = 
energy expenditure sitting at rest (I). Nonetheless, the 
physical stress of employment is still the greatest challenge 
to the cardiovascular system of many patients with ischemic 
heart disease. 
For many sedentary jobs posing limited psychological or 
environmental demands, the adequacy of the patient’s phys- 
ical working capacity can be assessed by a medical history, 
physical examination and symptom-limited exercise testing. 
However, as the physical demands of the job tasks increase 
to include exercise of widely varying intensities and types, 
or substantial psychological or environmental stress, assess- 
ment of physical working capacity becomes more complex. 
In patients with ischemic heart disease, the focus of 
occupational work evaluation is to determine whether or not 
the increase in cardiac demands produced by physical, 
psychological and environmental stressors will exceed the 
threshold for a “safe working capacity.” The challenge to 
the physician is to obtain an accurate, valid and reliable 
determination of this capacity. 
Factors Influencing Metabolic and 
Cardiovascular Demands During Work 
Physical exertion increases metabolic and cardiac de- 
mands roughly in proportion to the absolute intensity of the 
exertion. The magnitude of effort required for a particular 
task by an individual is related to the individual’s physical 
working capacity. Therefore, the metabolic and cardiac 
demands on an individual are related to characteristics of the 
task. such as the work intensity, type of work, size of muscle 
mass involved. work-rest cycle and environmental condi- 
tions as well as characteristics of the patient including 
cardiovascular function, skeletal muscle training and psy- 
chological factors (2). 
1. Types of Exercise Encountered in 
Occupational Tasks 
Occupational tasks require different types of exertion, 
performed singly and in combination, and vary in the num- 
ber and mass of muscle groups involved. The major types of 
exercise usually performed are dynumic (isotonic) and static 
(isometric), or a combination of both dynamic and static 
exertion. 
